These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6805233)

  • 1. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
    Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
    Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
    Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
    Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
    Jacobson RR; Trautman JR
    Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriological status (point prevalence) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Almeida JO; Araujo Arantes MA
    Bull World Health Organ; 1975; 52(1):57-62. PubMed ID: 764995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical stages in sulfone treatment of leprosy.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411
    [No Abstract]   [Full Text] [Related]  

  • 6. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Marques RM
    Int J Lepr Other Mycobact Dis; 1970; 38(3):250-63. PubMed ID: 4993550
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
    Shepard CC; Tolentino JG; McRae DH
    Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
    Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of leprosy--effect of the anti-leprotic agent on the growth of acid-fast bacilli in cutaneous and mucous tissue].
    Hirano E
    Iryo; 1972 Mar; 26(3):243-53. PubMed ID: 4554827
    [No Abstract]   [Full Text] [Related]  

  • 13. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in leprosy.
    Pettit JH
    Australas J Dermatol; 1968 Dec; 9(4):285-93. PubMed ID: 4886556
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of polymerase chain reaction for the detection of Mycobacterium leprae DNA in specimens from treated leprosy patients.
    Rafi A; Donoghue HD; Stanford JL
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):42-7. PubMed ID: 7730718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 19. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium leprae in skin and nasal scrapings during sulfone treatment; a review of 146 cases.
    BYERS JL; WOLCOTT RR
    Int J Lepr; 1954; 22(3):285-7. PubMed ID: 13232776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.